- had
previously received treatment - and were
given either Viekira Pak and (RBV) or
Viekira Pak alone.
Pearl II
reported a 100% cure rate.
Pearl III was...
-
vidofludimus (INN)
Vidprevtyn Beta
vidupiprant (INN)
Viekira Pak (Copackaged)
Viekira Xr
Viekira Viekirax Vienva vigabatrin (INN)
Vigadrone Vigafyde Vigamox...
- paritaprevir, and
ritonavir in the
product Viekira Pak can
cause a
number of
adverse effects. When
Viekira Pak was used
without ribavirin, nausea, severe...
-
Paritaprevir was a
component of
Viekira Pak and Technivie. In May 2018, the FDA
announced that
Technivie and
Viekira were to be discontinued. The discontinuation...
-
combination with paritaprevir,
ritonavir and
dasabuvir in the
product Viekira Pak for the
treatment of HCV
genotype 1, and with
paritaprevir and ritonavir...
-
StatPearls Publishing. PMID 31335032.
Retrieved January 6, 2024. "FDA
approves Viekira Pak to
treat hepatitis C" (Press release). U.S. Food and Drug Administration...
- NS5A inhibitors. Beclabuvir,
currently in
clinical trials.
Dasabuvir (
Viekira Pak), non-nucleoside/nucleotide analog,
approved by FDA in
December 2014...
-
treatments include Gilead's
Harvoni (sofosbuvir and ledipasvir) and AbbVie's
Viekira Pak (ombitasvir, paritaprevir, and ritonavir). Sale
projections for Zepatier...
